Fresenius Se & Company Kg ADR (FSNUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSNUY | DGX | ELAN | DVA | EHC |
| Company | Fresenius Se & Company Kg ADR | Quest Diagnostics Inc | Elanco Animal Health Inc | Davita Healthcare Partners Inc | Encompass Health Corp |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NYSE |
| Open | 9.3350 | 155.10 | 14.85 | 163.13 | 91.91 |
| High | 9.3350 | 155.10 | 14.90 | 165.17 | 92.71 |
| Low | 9.2050 | 152.56 | 14.04 | 161.67 | 90.87 |
| Last | 9.3120 | 152.99 | 14.07 | 164.00 | 92.65 |
| Change | -0.1880 | -2.13 | -1.00 | +0.86 | +0.59 |
| % Change | -1.98% | -1.37% | -6.64% | +0.53% | +0.64% |
| Volume | 16,100 | 1,456,200 | 8,880,000 | 2,139,200 | 1,467,700 |
| 20-Day Average Volume | 22,750 | 692,480 | 4,546,245 | 799,055 | 492,825 |
| Previous Close | 9.5000 | 155.12 | 15.07 | 163.14 | 92.06 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.3716 | 154.69 | 14.81 | 156.10 | 92.23 |
| 20-Day Raw Stochastic | 35.46% | 35.26% | 15.35% | 88.95% | 57.27% |
| 20-Day Relative Strength | 57.11% | 52.85% | 45.92% | 67.69% | 56.73% |
| Weighted Alpha | +25.07 | +24.95 | +9.68 | +72.74 | +35.41 |
| Today's Opinion | 88% Buy | 80% Buy | 48% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 16% Sell | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.10% since 09/13/24 | -0.90% since 09/13/24 | -2.76% since 09/13/24 | +0.27% since 09/13/24 | -0.64% since 09/13/24 |
| Low | 9.2050 on 09/20/24 | 152.56 on 09/20/24 | 13.76 on 09/19/24 | 160.02 on 09/18/24 | 90.72 on 09/18/24 |
| High | 9.6300 on 09/18/24 | 157.23 on 09/16/24 | 15.78 on 09/19/24 | 166.04 on 09/19/24 | 94.59 on 09/16/24 |
| 1-Month | |||||
| %Chg | +3.93% since 08/20/24 | +1.38% since 08/20/24 | -4.16% since 08/20/24 | +11.13% since 08/20/24 | +4.54% since 08/20/24 |
| Low | 9.0070 on 08/21/24 | 149.52 on 09/11/24 | 13.76 on 09/19/24 | 147.58 on 08/30/24 | 88.38 on 08/21/24 |
| High | 9.7160 on 09/13/24 | 159.36 on 09/04/24 | 15.78 on 09/19/24 | 166.04 on 09/19/24 | 94.59 on 09/16/24 |
| 3-Month | |||||
| %Chg | +22.36% since 06/20/24 | +10.70% since 06/20/24 | -22.69% since 06/20/24 | +16.94% since 06/20/24 | +9.67% since 06/20/24 |
| Low | 7.4300 on 06/28/24 | 135.47 on 06/28/24 | 11.40 on 08/08/24 | 131.76 on 08/07/24 | 82.74 on 08/06/24 |
| High | 9.7160 on 09/13/24 | 159.36 on 09/04/24 | 18.55 on 06/24/24 | 166.04 on 09/19/24 | 94.59 on 09/16/24 |
| 6-Month | |||||
| %Chg | +36.39% since 03/20/24 | +19.79% since 03/20/24 | -13.04% since 03/20/24 | +18.17% since 03/20/24 | +20.84% since 03/20/24 |
| Low | 6.5700 on 04/02/24 | 125.42 on 04/18/24 | 11.40 on 08/08/24 | 125.64 on 04/18/24 | 76.11 on 03/26/24 |
| High | 9.7160 on 09/13/24 | 159.36 on 09/04/24 | 18.80 on 06/12/24 | 166.04 on 09/19/24 | 94.59 on 09/16/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 21,223,084 | 17,232,592 | 7,447,323 | 14,307,376 | 9,269,060 |
| Shares Outstanding, K | 2,234,009 | 111,092 | 494,182 | 87,700 | 100,685 |
| Annual Sales | 24,011,410,000 | 9,252,000,000 | 4,417,000,000 | 12,140,150,000 | 4,801,200,000 |
| Annual Net Income | -639,620,000 | 854,000,000 | -1,231,000,000 | 691,540,000 | 352,000,000 |
| Last Quarter Sales | 5,827,680,000 | 2,397,000,000 | 1,184,000,000 | 3,186,720,000 | 1,301,200,000 |
| Last Quarter Net Income | -401,500,000 | 229,000,000 | -50,000,000 | 222,680,000 | 114,100,000 |
| 60-Month Beta | 1.05 | 0.89 | 1.40 | 0.87 | 0.88 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 07/31/24 | 2.35 on 07/23/24 | 0.30 on 08/08/24 | 2.59 on 08/06/24 | 1.11 on 08/05/24 |
| Latest Earnings Date | 11/07/24 | 10/22/24 | 11/05/24 | 11/05/24 | 10/24/24 |
| Most Recent Dividend | 0.167 on 05/18/23 | 0.750 on 07/08/24 | N/A | N/A | 0.150 on 06/28/24 |
| Next Ex-Dividends Date | 05/18/23 | 10/04/24 | N/A | N/A | 10/01/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.75 | 16.28 | 16.84 | 22.88 |